Observational Study of Afatinib 30 mg Daily

Clinical trial NCT04909073 · UNKNOWN

Trial details

NCT number: NCT04909073
Sponsor: National University Hospital, Singapore
Status: UNKNOWN
Study type: OBSERVATIONAL

Non-Small Cell Lung Cancer Epidermal Growth Factor Receptor Mutation

Start date: 2022-10-25
Primary completion: 2025-05-01
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.